Are Sham Acupuncture Interventions More Effective than (Other) Placebos? A Re-Analysis of Data from the Cochrane Review on Placebo Effects

被引:101
|
作者
Linde, Klaus [1 ]
Niemann, Karin [1 ]
Meissner, Karin [1 ,2 ]
机构
[1] Tech Univ Munich, Inst Gen Practice, D-81667 Munich, Germany
[2] Univ Munich, Inst Med Psychol, D-8000 Munich, Germany
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2010年 / 17卷 / 05期
关键词
Acupuncture; Placebo effects; Sham acupuncture; Randomized controlled trial; Meta-analysis; LOW-BACK-PAIN; RANDOMIZED CONTROLLED-TRIAL; ELECTROACUPUNCTURE; OSTEOARTHRITIS; KNEE; DEPRESSION; MANAGEMENT; EFFICACY; MIGRAINE; MEDICINE;
D O I
10.1159/000320374
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background and Objective: A recent Cochrane review on placebo interventions for all kinds of conditions found that 'physical placebos' (which included sham acupuncture) were associated with larger effects over no-treatment control groups than 'pharmacological placebos'. We re-analyzed the data from this review to investigate whether effects associated with sham acupuncture differed from those of other 'physical placebos'. Methods: All trials included in the Cochrane review as investigating 'physical placebos' were classified as investigating either (sham) acupuncture or other physical placebos. The latter group was further subclassified into groups of similar interventions. Data from the Cochrane review were re-entered into the RevMan 5 software for meta-analysis. The primary analysis was a random-effects analysis of trials reporting continuous outcomes of trials that used either sham acupuncture or other physical placebos. Results: Out of a total of 61 trials which reported a continuous outcome measure, 19 compared sham acupuncture and 42 compared other physical placebos with a no-treatment control group. The trials re-analyzed were highly heterogeneous regarding patients, interventions and outcomes measured. The pooled standardized mean difference was -0.41 (95% confidence interval -0.56, -0.24) between sham acupuncture and no treatment and -0.26 (95% CI -0.37, -0.15) between other physical placebos and no treatment (p value for subgroup differences = 0.007). Significant differences were also observed between subgroups of other physical placebos. Conclusion: Due to the heterogeneity of the trials included and the indirect comparison our results must be interpreted with caution. Still, they suggest that sham acupuncture interventions might, on average, be associated with larger effects than pharmacological and other physical placebos.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 47 条
  • [31] Equity-specific effects of interventions to promote physical activity among middle-aged and older adults: results from applying a novel equity-specific re-analysis strategy
    Czwikla, Gesa
    Boen, Filip
    Cook, Derek G.
    de Jong, Johan
    Harris, Tess
    Hilz, Lisa K.
    Iliffe, Steve
    Lechner, Lilian
    Morris, Richard W.
    Muellmann, Saskia
    Peels, Denise A.
    Pischke, Claudia R.
    Schuz, Benjamin
    Stevens, Martin
    Telkmann, Klaus
    van Lenthe, Frank J.
    Vanderlinden, Julie
    Bolte, Gabriele
    INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY, 2021, 18 (01)
  • [32] Is computer-assisted instruction more effective than other educational methods in achieving ECG competence among medical students and residents? Protocol for a systematic review and meta-analysis
    Viljoen, Charle Andre
    Millar, Rob Scott
    Engel, Mark E.
    Shelton, Mary
    Burch, Vanessa
    BMJ OPEN, 2017, 7 (12):
  • [33] Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial
    Di Molfetta, Sergio
    Bosi, Emanuele
    Ceriello, Antonio
    Cucinotta, Domenico
    Tiengo, Antonio
    Scavini, Marina
    Piccolo, Carmine
    Bonizzoni, Erminio
    Acmet, Elena
    Giorgino, Francesco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 181
  • [34] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Blumenfeld, Andrew
    Buse, Dawn
    Turner, Ira
    Stock, David A.
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2019, 39 : 202 - 202
  • [35] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-nflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Turner, Ira
    Buse, Dawn
    Blumenfeld, Andrew
    Stock, Elyse
    Stock, David
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
  • [36] Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine A preliminary report of re-analyses of data from a Cochrane Database Systematic Review
    Takeuchi, Masato
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1421 - 1424
  • [37] Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis
    Bashir, Rohina
    Asrar, Mir Mahmood
    Shah, Idrees Ayoub
    Wani, Imtiyaz Ahmad
    Ganie, Mohd. Ashraf
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (19) : 1486 - 1496
  • [38] Rimegepant 75 mg Is More Effective Than Nonsteroidal Anti-inflammatory Drugs for the Acute Treatment of Migraine: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Blumenfeld, A. M.
    Buse, D.
    Turner, I. M.
    Stock, D. A.
    Morris, B. A.
    Coric, V
    Croop, R.
    HEADACHE, 2019, 59 : 182 - 183
  • [39] Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis
    Gouraud, Henri
    Wallach, Joshua D.
    Boussageon, Remy
    Ross, Joseph S.
    Naudet, Florian
    BMJ MEDICINE, 2022, 1 (01):
  • [40] Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis
    Kerwin, E. M.
    Mahler, D. A.
    Fuale, S.
    Yadao, A.
    Thach, C.
    Taylor, A. Fowler
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195